The global Pharmaceutical Release Testing market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Release testing covers a variety of tests to address the purity, concentration, consistency, identity and safety of the product. Typical testing would comprise of appearance, assay and impurities, dissolution and microbial testing.Good Manufacturing Practice (GMP) batch release testing is a necessary requirement to ensure high quality pharmaceuticals and biopharmaceuticals prior to release for sale, supply or export.A batch release is a certification of a medicinal product or a drug by an authorized person. The batch release must be done before the products are introduced into free trade.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Pharmaceutical Release Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pharmaceutical Release Testing market size and forecasts, in consumption value ($ Million), 2020-2031
Global Pharmaceutical Release Testing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Pharmaceutical Release Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Pharmaceutical Release Testing market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical Release Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical Release Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Intertek, Eurofins, SGS, Almac, Excite Pharma Services, Charles River Laboratories, Bio-Rad, Element, Merck, Boston Analytical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Pharmaceutical Release Testing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chemical Testing
Physical Testing
Market segment by Application
Big Pharmaceutical Companies
Small and Medium Pharmaceutical Companies
Market segment by players, this report covers
Intertek
Eurofins
SGS
Almac
Excite Pharma Services
Charles River Laboratories
Bio-Rad
Element
Merck
Boston Analytical
ALS Life Sciences
Reading Scientific Services
Lucideon
Tepnel Pharma Services
Nutrasource
Vetter Pharma
WESSLING
TUV SUD
Sotax
Pace Analytical
Tergus Pharma
Symbiosis
Broughton Group
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pharmaceutical Release Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmaceutical Release Testing, with revenue, gross margin, and global market share of Pharmaceutical Release Testing from 2020 to 2025.
Chapter 3, the Pharmaceutical Release Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Pharmaceutical Release Testing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical Release Testing.
Chapter 13, to describe Pharmaceutical Release Testing research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Pharmaceutical Release Testing by Type
1.3.1 Overview: Global Pharmaceutical Release Testing Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Pharmaceutical Release Testing Consumption Value Market Share by Type in 2024
1.3.3 Chemical Testing
1.3.4 Physical Testing
1.4 Global Pharmaceutical Release Testing Market by Application
1.4.1 Overview: Global Pharmaceutical Release Testing Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Big Pharmaceutical Companies
1.4.3 Small and Medium Pharmaceutical Companies
1.5 Global Pharmaceutical Release Testing Market Size & Forecast
1.6 Global Pharmaceutical Release Testing Market Size and Forecast by Region
1.6.1 Global Pharmaceutical Release Testing Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Pharmaceutical Release Testing Market Size by Region, (2020-2031)
1.6.3 North America Pharmaceutical Release Testing Market Size and Prospect (2020-2031)
1.6.4 Europe Pharmaceutical Release Testing Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Pharmaceutical Release Testing Market Size and Prospect (2020-2031)
1.6.6 South America Pharmaceutical Release Testing Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Pharmaceutical Release Testing Market Size and Prospect (2020-2031)
2 Company Profiles
2.1 Intertek
2.1.1 Intertek Details
2.1.2 Intertek Major Business
2.1.3 Intertek Pharmaceutical Release Testing Product and Solutions
2.1.4 Intertek Pharmaceutical Release Testing Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Intertek Recent Developments and Future Plans
2.2 Eurofins
2.2.1 Eurofins Details
2.2.2 Eurofins Major Business
2.2.3 Eurofins Pharmaceutical Release Testing Product and Solutions
2.2.4 Eurofins Pharmaceutical Release Testing Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Eurofins Recent Developments and Future Plans
2.3 SGS
2.3.1 SGS Details
2.3.2 SGS Major Business
2.3.3 SGS Pharmaceutical Release Testing Product and Solutions
2.3.4 SGS Pharmaceutical Release Testing Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 SGS Recent Developments and Future Plans
2.4 Almac
2.4.1 Almac Details
2.4.2 Almac Major Business
2.4.3 Almac Pharmaceutical Release Testing Product and Solutions
2.4.4 Almac Pharmaceutical Release Testing Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Almac Recent Developments and Future Plans
2.5 Excite Pharma Services
2.5.1 Excite Pharma Services Details
2.5.2 Excite Pharma Services Major Business
2.5.3 Excite Pharma Services Pharmaceutical Release Testing Product and Solutions
2.5.4 Excite Pharma Services Pharmaceutical Release Testing Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Excite Pharma Services Recent Developments and Future Plans
2.6 Charles River Laboratories
2.6.1 Charles River Laboratories Details
2.6.2 Charles River Laboratories Major Business
2.6.3 Charles River Laboratories Pharmaceutical Release Testing Product and Solutions
2.6.4 Charles River Laboratories Pharmaceutical Release Testing Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Charles River Laboratories Recent Developments and Future Plans
2.7 Bio-Rad
2.7.1 Bio-Rad Details
2.7.2 Bio-Rad Major Business
2.7.3 Bio-Rad Pharmaceutical Release Testing Product and Solutions
2.7.4 Bio-Rad Pharmaceutical Release Testing Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Bio-Rad Recent Developments and Future Plans
2.8 Element
2.8.1 Element Details
2.8.2 Element Major Business
2.8.3 Element Pharmaceutical Release Testing Product and Solutions
2.8.4 Element Pharmaceutical Release Testing Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Element Recent Developments and Future Plans
2.9 Merck
2.9.1 Merck Details
2.9.2 Merck Major Business
2.9.3 Merck Pharmaceutical Release Testing Product and Solutions
2.9.4 Merck Pharmaceutical Release Testing Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Merck Recent Developments and Future Plans
2.10 Boston Analytical
2.10.1 Boston Analytical Details
2.10.2 Boston Analytical Major Business
2.10.3 Boston Analytical Pharmaceutical Release Testing Product and Solutions
2.10.4 Boston Analytical Pharmaceutical Release Testing Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Boston Analytical Recent Developments and Future Plans
2.11 ALS Life Sciences
2.11.1 ALS Life Sciences Details
2.11.2 ALS Life Sciences Major Business
2.11.3 ALS Life Sciences Pharmaceutical Release Testing Product and Solutions
2.11.4 ALS Life Sciences Pharmaceutical Release Testing Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 ALS Life Sciences Recent Developments and Future Plans
2.12 Reading Scientific Services
2.12.1 Reading Scientific Services Details
2.12.2 Reading Scientific Services Major Business
2.12.3 Reading Scientific Services Pharmaceutical Release Testing Product and Solutions
2.12.4 Reading Scientific Services Pharmaceutical Release Testing Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Reading Scientific Services Recent Developments and Future Plans
2.13 Lucideon
2.13.1 Lucideon Details
2.13.2 Lucideon Major Business
2.13.3 Lucideon Pharmaceutical Release Testing Product and Solutions
2.13.4 Lucideon Pharmaceutical Release Testing Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Lucideon Recent Developments and Future Plans
2.14 Tepnel Pharma Services
2.14.1 Tepnel Pharma Services Details
2.14.2 Tepnel Pharma Services Major Business
2.14.3 Tepnel Pharma Services Pharmaceutical Release Testing Product and Solutions
2.14.4 Tepnel Pharma Services Pharmaceutical Release Testing Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Tepnel Pharma Services Recent Developments and Future Plans
2.15 Nutrasource
2.15.1 Nutrasource Details
2.15.2 Nutrasource Major Business
2.15.3 Nutrasource Pharmaceutical Release Testing Product and Solutions
2.15.4 Nutrasource Pharmaceutical Release Testing Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Nutrasource Recent Developments and Future Plans
2.16 Vetter Pharma
2.16.1 Vetter Pharma Details
2.16.2 Vetter Pharma Major Business
2.16.3 Vetter Pharma Pharmaceutical Release Testing Product and Solutions
2.16.4 Vetter Pharma Pharmaceutical Release Testing Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Vetter Pharma Recent Developments and Future Plans
2.17 WESSLING
2.17.1 WESSLING Details
2.17.2 WESSLING Major Business
2.17.3 WESSLING Pharmaceutical Release Testing Product and Solutions
2.17.4 WESSLING Pharmaceutical Release Testing Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 WESSLING Recent Developments and Future Plans
2.18 TUV SUD
2.18.1 TUV SUD Details
2.18.2 TUV SUD Major Business
2.18.3 TUV SUD Pharmaceutical Release Testing Product and Solutions
2.18.4 TUV SUD Pharmaceutical Release Testing Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 TUV SUD Recent Developments and Future Plans
2.19 Sotax
2.19.1 Sotax Details
2.19.2 Sotax Major Business
2.19.3 Sotax Pharmaceutical Release Testing Product and Solutions
2.19.4 Sotax Pharmaceutical Release Testing Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 Sotax Recent Developments and Future Plans
2.20 Pace Analytical
2.20.1 Pace Analytical Details
2.20.2 Pace Analytical Major Business
2.20.3 Pace Analytical Pharmaceutical Release Testing Product and Solutions
2.20.4 Pace Analytical Pharmaceutical Release Testing Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 Pace Analytical Recent Developments and Future Plans
2.21 Tergus Pharma
2.21.1 Tergus Pharma Details
2.21.2 Tergus Pharma Major Business
2.21.3 Tergus Pharma Pharmaceutical Release Testing Product and Solutions
2.21.4 Tergus Pharma Pharmaceutical Release Testing Revenue, Gross Margin and Market Share (2020-2025)
2.21.5 Tergus Pharma Recent Developments and Future Plans
2.22 Symbiosis
2.22.1 Symbiosis Details
2.22.2 Symbiosis Major Business
2.22.3 Symbiosis Pharmaceutical Release Testing Product and Solutions
2.22.4 Symbiosis Pharmaceutical Release Testing Revenue, Gross Margin and Market Share (2020-2025)
2.22.5 Symbiosis Recent Developments and Future Plans
2.23 Broughton Group
2.23.1 Broughton Group Details
2.23.2 Broughton Group Major Business
2.23.3 Broughton Group Pharmaceutical Release Testing Product and Solutions
2.23.4 Broughton Group Pharmaceutical Release Testing Revenue, Gross Margin and Market Share (2020-2025)
2.23.5 Broughton Group Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Pharmaceutical Release Testing Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Pharmaceutical Release Testing by Company Revenue
3.2.2 Top 3 Pharmaceutical Release Testing Players Market Share in 2024
3.2.3 Top 6 Pharmaceutical Release Testing Players Market Share in 2024
3.3 Pharmaceutical Release Testing Market: Overall Company Footprint Analysis
3.3.1 Pharmaceutical Release Testing Market: Region Footprint
3.3.2 Pharmaceutical Release Testing Market: Company Product Type Footprint
3.3.3 Pharmaceutical Release Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Pharmaceutical Release Testing Consumption Value and Market Share by Type (2020-2025)
4.2 Global Pharmaceutical Release Testing Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
5.1 Global Pharmaceutical Release Testing Consumption Value Market Share by Application (2020-2025)
5.2 Global Pharmaceutical Release Testing Market Forecast by Application (2026-2031)
6 North America
6.1 North America Pharmaceutical Release Testing Consumption Value by Type (2020-2031)
6.2 North America Pharmaceutical Release Testing Market Size by Application (2020-2031)
6.3 North America Pharmaceutical Release Testing Market Size by Country
6.3.1 North America Pharmaceutical Release Testing Consumption Value by Country (2020-2031)
6.3.2 United States Pharmaceutical Release Testing Market Size and Forecast (2020-2031)
6.3.3 Canada Pharmaceutical Release Testing Market Size and Forecast (2020-2031)
6.3.4 Mexico Pharmaceutical Release Testing Market Size and Forecast (2020-2031)
7 Europe
7.1 Europe Pharmaceutical Release Testing Consumption Value by Type (2020-2031)
7.2 Europe Pharmaceutical Release Testing Consumption Value by Application (2020-2031)
7.3 Europe Pharmaceutical Release Testing Market Size by Country
7.3.1 Europe Pharmaceutical Release Testing Consumption Value by Country (2020-2031)
7.3.2 Germany Pharmaceutical Release Testing Market Size and Forecast (2020-2031)
7.3.3 France Pharmaceutical Release Testing Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Pharmaceutical Release Testing Market Size and Forecast (2020-2031)
7.3.5 Russia Pharmaceutical Release Testing Market Size and Forecast (2020-2031)
7.3.6 Italy Pharmaceutical Release Testing Market Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Release Testing Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Pharmaceutical Release Testing Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Pharmaceutical Release Testing Market Size by Region
8.3.1 Asia-Pacific Pharmaceutical Release Testing Consumption Value by Region (2020-2031)
8.3.2 China Pharmaceutical Release Testing Market Size and Forecast (2020-2031)
8.3.3 Japan Pharmaceutical Release Testing Market Size and Forecast (2020-2031)
8.3.4 South Korea Pharmaceutical Release Testing Market Size and Forecast (2020-2031)
8.3.5 India Pharmaceutical Release Testing Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Pharmaceutical Release Testing Market Size and Forecast (2020-2031)
8.3.7 Australia Pharmaceutical Release Testing Market Size and Forecast (2020-2031)
9 South America
9.1 South America Pharmaceutical Release Testing Consumption Value by Type (2020-2031)
9.2 South America Pharmaceutical Release Testing Consumption Value by Application (2020-2031)
9.3 South America Pharmaceutical Release Testing Market Size by Country
9.3.1 South America Pharmaceutical Release Testing Consumption Value by Country (2020-2031)
9.3.2 Brazil Pharmaceutical Release Testing Market Size and Forecast (2020-2031)
9.3.3 Argentina Pharmaceutical Release Testing Market Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Release Testing Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Pharmaceutical Release Testing Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Pharmaceutical Release Testing Market Size by Country
10.3.1 Middle East & Africa Pharmaceutical Release Testing Consumption Value by Country (2020-2031)
10.3.2 Turkey Pharmaceutical Release Testing Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Pharmaceutical Release Testing Market Size and Forecast (2020-2031)
10.3.4 UAE Pharmaceutical Release Testing Market Size and Forecast (2020-2031)
11 Market Dynamics
11.1 Pharmaceutical Release Testing Market Drivers
11.2 Pharmaceutical Release Testing Market Restraints
11.3 Pharmaceutical Release Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Pharmaceutical Release Testing Industry Chain
12.2 Pharmaceutical Release Testing Upstream Analysis
12.3 Pharmaceutical Release Testing Midstream Analysis
12.4 Pharmaceutical Release Testing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Intertek
Eurofins
SGS
Almac
Excite Pharma Services
Charles River Laboratories
Bio-Rad
Element
Merck
Boston Analytical
ALS Life Sciences
Reading Scientific Services
Lucideon
Tepnel Pharma Services
Nutrasource
Vetter Pharma
WESSLING
TUV SUD
Sotax
Pace Analytical
Tergus Pharma
Symbiosis
Broughton Group
听
听
*If Applicable.